CY1116795T1 - CODES AND RELATED Molecules Binding to Protein TOY PSCA - Google Patents

CODES AND RELATED Molecules Binding to Protein TOY PSCA

Info

Publication number
CY1116795T1
CY1116795T1 CY20151100913T CY151100913T CY1116795T1 CY 1116795 T1 CY1116795 T1 CY 1116795T1 CY 20151100913 T CY20151100913 T CY 20151100913T CY 151100913 T CY151100913 T CY 151100913T CY 1116795 T1 CY1116795 T1 CY 1116795T1
Authority
CY
Cyprus
Prior art keywords
psca
protein
toy
codes
related molecules
Prior art date
Application number
CY20151100913T
Other languages
Greek (el)
Inventor
Jean Gudas
Aya Jakobovits
Xiao-Chi Jia
Robert Kendall Morrison
Karen Jane Mayrick Morrison
Hui Shao
Pia M Challita-Eid
Arthur B Raitano
Original Assignee
Agensys, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/857,484 external-priority patent/US7622564B2/en
Priority claimed from EP05752076.9A external-priority patent/EP1753871B1/en
Application filed by Agensys, Inc. filed Critical Agensys, Inc.
Publication of CY1116795T1 publication Critical patent/CY1116795T1/en

Links

Abstract

Αντισώματα και μόρια που προέρχονται από αυτά που δεσμεύονται σε καινοφανή πρωτεΐνη του PSCA και παραλλάγματα εξ αυτών περιγράφονται όπου το PSCA εκδηλώνει συγκεκριμένη για ιστούς έκφραση σε φυσιολογικό ιστό ενηλίκων, και εκφράζεται κατά παρεκκλίνοντα τρόπο στους καρκίνους που καταλογογραφούνται στον Πίνακα I. Επακόλουθα, το PSCA παρέχει διαγνωστικό, προγνωστικό, προφυλακτικό και/ή θεραπευτικό στόχο για καρκίνο. Το γονίδιο του PSCA ή το θραύσμα εξ αυτού, ή η εγκωδικευθείσα πρωτεΐνη αυτού, ή τα παραλλάγματα εξ αυτής, ή ένα θραύσμα εξ αυτής, μπορούν να χρησιμοποιηθούν για να εκμαιευθεί χυμική ή κυτταρική ανοσιακή απόκριση• αντισώματα ή κύτταρα Τ δραστικά με το PSCA μπορούν να χρησιμοποιηθούν σε ενεργητική ή παθητική ανοσοποίηση.Antibodies and molecules derived from those that bind to a novel PSCA protein and variants thereof are described where the PSCA expresses tissue-specific expression in normal adult tissue, and is expressed in derogation to the cancers listed in Table I. diagnostic, prognostic, prophylactic and / or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, may be used to elicit a humoral or cellular immune response; antibodies or T cells active with PSCA may used in active or passive immunization.

CY20151100913T 2004-05-28 2015-10-09 CODES AND RELATED Molecules Binding to Protein TOY PSCA CY1116795T1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/857,484 US7622564B2 (en) 2003-05-30 2004-05-28 Prostate stem cell antigen (PSCA) variants and subsequences thereof
US61638104A 2004-10-05 2004-10-05
US61788104A 2004-10-12 2004-10-12
US62131004A 2004-10-21 2004-10-21
US63307704A 2004-12-02 2004-12-02
US67200005A 2005-04-14 2005-04-14
EP05752076.9A EP1753871B1 (en) 2004-05-28 2005-05-17 Antibodies and related molecules that bind to psca proteins

Publications (1)

Publication Number Publication Date
CY1116795T1 true CY1116795T1 (en) 2017-03-15

Family

ID=58459739

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100913T CY1116795T1 (en) 2004-05-28 2015-10-09 CODES AND RELATED Molecules Binding to Protein TOY PSCA

Country Status (1)

Country Link
CY (1) CY1116795T1 (en)

Similar Documents

Publication Publication Date Title
CY1114855T1 (en) ANTIBODIES AND PARTS COMING FROM THESE BINDING TO PROTEINS TOY STEAP-1
CY1113044T1 (en) EXTERNAL ANTIGEN CELL PROTECTOR CELL EXTRACTS (PSCA) AND SUBSEQUENTS OF THESE
CY1113247T1 (en) NUCLEAR ACIDS WITH THE TITLE 273P4B7 AND USE IN CANCER TEST
CY1114069T1 (en) NUCLEAR ACID AND COMPATIBLE PROTEIN WITH TITLE 161P2F10B USEFUL IN CANCER TREATMENT AND DETECTION
CY1121353T1 (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1123400T1 (en) HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
CY1117963T1 (en) IL-17A AND IL-17F ANTIBODIES
WO2005118864A3 (en) Antibodies and related molecules that bind to psca proteins
WO2009033094A3 (en) Antibodies and related molecules that bind to 24p4c12 proteins
WO2006105488A3 (en) Antibodies and related molecules that bind to 161p2f10b proteins
DE602004018927D1 (en) MODIFIED RECOMBINANT VACCINIA VIRUSES, USES THEREOF
TW200635946A (en) Binding proteins specific for human matriptase
DK1572087T3 (en) Antibodies with cancer antigen TMEFF2 and applications thereof
BRPI0411854A (en) protein vehicles for vaccines
PE20050962A1 (en) FULLY HUMAN ANTIBODIES VS HUMAN 4-1BB
DE60315827D1 (en) IMPROVED POLYSACCHARIDE AND GLYCOCONJUGATE VACCINE
UY26266A1 (en) ANTIGEN ASSOCIATED WITH TUMORS (R11) LAW 17164
CY1116795T1 (en) CODES AND RELATED Molecules Binding to Protein TOY PSCA
EP1778284A4 (en) Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer
UY26170A1 (en) ANTIGEN (C42) ASSOCIATED WITH TUMORS
CY1114674T1 (en) ANTIBODIES AND RELATED Molecules Associated With 24P4C12 Proteins
CY1113332T1 (en) NUCLEAR ACIDS AND RELATED PROTEINS NAMED 191P4D12 (B) USEFUL IN CANCER EDUCATION AND DETECTION
NO20075592L (en) Antibodies and related molecules that bind to PSCA Proteins
CY1112424T1 (en) NUCLEAR ACID AND CORRESPONDING PROTEIN WITH TITLE 238P1B2 USEFUL IN CANCER EDUCATION AND DETECTION